Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	851	1,357	1,806	3,318	3,740	-	Upgrade
Market Cap Growth	-	-24.86%	-45.57%	-11.28%	-	-	Upgrade
Enterprise Value	151	658	862	2,380	3,085	-332	Upgrade
PE Ratio	-3.31	-3.97	-6.22	-9.12	-16.25	-	Upgrade
PS Ratio	24.09	53.13	1307.87	1095.42	45.25	-	Upgrade
PB Ratio	1.14	1.81	1.90	3.70	4.90	-	Upgrade
P/FCF Ratio	-3.79	-4.46	-7.57	-42.61	-35.81	-	Upgrade
P/OCF Ratio	-3.84	-4.52	-7.87	-44.59	-36.49	-	Upgrade
EV/Sales Ratio	4.27	25.75	624.49	785.83	37.33	-	Upgrade
EV/EBITDA Ratio	-1.20	-1.95	-3.01	-6.61	-63.14	4.58	Upgrade
EV/EBIT Ratio	-1.18	-1.92	-2.97	-6.54	-58.87	4.41	Upgrade
EV/FCF Ratio	-1.35	-2.16	-3.62	-30.56	-29.55	4.48	Upgrade
Debt / Equity Ratio	0.07	0.07	0.06	0.03	0.03	-0.14	Upgrade
Debt / EBITDA Ratio	-0.16	-0.16	-0.20	-0.06	-0.50	-0.34	Upgrade
Debt / FCF Ratio	-0.18	-0.18	-0.24	-0.29	-0.23	-0.34	Upgrade
Quick Ratio	20.25	24.87	15.72	39.52	55.31	29.76	Upgrade
Current Ratio	20.73	25.44	16.00	40.14	56.49	30.08	Upgrade
Asset Turnover	0.04	0.03	0.00	0.00	0.15	0	Upgrade
Return on Equity (ROE)	-42.70%	-42.40%	-32.50%	-51.60%	-87.80%	51.70%	Upgrade
Return on Assets (ROA)	-37.00%	-36.50%	-28.30%	-46.00%	-40.60%	-18.30%	Upgrade
Return on Capital (ROIC)	-46.29%	-47.11%	-30.85%	-39.30%	-7.08%	54.01%	Upgrade
Earnings Yield	-38.68%	-25.20%	-16.08%	-10.97%	-6.16%	-	Upgrade
FCF Yield	-33.79%	-22.43%	-13.21%	-2.35%	-2.79%	-	Upgrade
Buyback Yield / Dilution	-7.85%	-9.22%	-17.97%	-123.22%	-1135.17%	-38.84%	Upgrade
Total Shareholder Return	-7.85%	-9.22%	-17.97%	-123.22%	-1135.17%	-38.84%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).